161

Public Health & Prevention
Focuses on global human health and epidemic prevention.
Sub Categories on Public Health & Prevention
Latest Articles
How a novel drug pushes the HIV capsid to breaking point

How a novel drug pushes the HIV capsid to breaking point

by University of New South WalesLenacapavir causes the HIV capsid to rupture before it can transport its genetic material to the host cell nucleus. Credit: Public Health Image Library, CDCJust ov

How a novel drug pushes the HIV capsid to breaking point

by University of New South WalesLenacapavir causes the HIV capsid to rupture before it can transport its genetic material to the host cell nucleus. Credit: Public Health Image Library, CDCJust ov
Antibody production in patients hospitalized with COVID-19

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV
Why has October been so bad for a virus known as RSV?

Why has October been so bad for a virus known as RSV?

by Harriet Blair RowanCredit: Pixabay/CC0 Public DomainOctober is usually a quiet month for Dr. Julie Kim and her colleagues at their pediatrics practice in Los Gatos, after the summer rush for physic

Why has October been so bad for a virus known as RSV?

by Harriet Blair RowanCredit: Pixabay/CC0 Public DomainOctober is usually a quiet month for Dr. Julie Kim and her colleagues at their pediatrics practice in Los Gatos, after the summer rush for physic
Vaccine to prevent a dangerous tropical disease receives approval

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea
Will COVID-19 vaccines need to be adapted regularly?

Will COVID-19 vaccines need to be adapted regularly?

by Charité - Universitätsmedizin BerlinJust like thephylogenetic tree of the influenza virus subtype H3N2 (right), the phylogenetic tree of the ‘common cold’ coronavirus 229E (left) shows a

Will COVID-19 vaccines need to be adapted regularly?

by Charité - Universitätsmedizin BerlinJust like thephylogenetic tree of the influenza virus subtype H3N2 (right), the phylogenetic tree of the ‘common cold’ coronavirus 229E (left) shows a
Internal tremors: Adding to the list of long COVID symptoms

Internal tremors: Adding to the list of long COVID symptoms

by Freda Kreier,Yale UniversityMost important symptoms for differentiating between participants with and without internal tremors. Credit:The American Journal of Medicine(2024). DOI:

Internal tremors: Adding to the list of long COVID symptoms

by Freda Kreier,Yale UniversityMost important symptoms for differentiating between participants with and without internal tremors. Credit:The American Journal of Medicine(2024). DOI:
A simple T-cell test to show the full picture of body's immune response to COVID-19

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases
Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo
HIV-infected cells persist in CSF in individuals on long-term ART

HIV-infected cells persist in CSF in individuals on long-term ART

(HealthDay)—About half of HIV-positive individuals on long-term antiretroviral therapy (ART) have HIV-infected cells in their cerebrospinal fluid (CSF), according to a study published online July 15 i

HIV-infected cells persist in CSF in individuals on long-term ART

(HealthDay)—About half of HIV-positive individuals on long-term antiretroviral therapy (ART) have HIV-infected cells in their cerebrospinal fluid (CSF), according to a study published online July 15 i
Type 1 IFNs may mediate Zika pregnancy complications

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I